Committee for Orphan Medicinal Products (COMP): 3-5 October 2017

EventHumanRare diseases

Polish is available via eTranslation, the European Commission's machine translation service.

Translate to Polish | Important information about machine translation

Date

wtorek, 3 Październik 2017, Cały dzień

Miejsce

European Medicines Agency, Amsterdam, the Netherlands

The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.

Documents

Minutes of the COMP meeting of 3-5 October 2017

Adopted Reference Number: EMA/COMP/649605/2017

English (EN) (320.22 KB - PDF)

Opublikowane po raz pierwszy: Ostatnia aktualizacja:
Zobacz

COMP meeting report on the review of applications for orphan designation: 3-5 October 2017

Reference Number: EMA/COMP/634206/2017

English (EN) (126.24 KB - PDF)

Opublikowane po raz pierwszy: Ostatnia aktualizacja:
Zobacz

Agenda - COMP agenda of the 3-5 October 2017 meeting

Draft Reference Number: EMA/COMP/606831/2017

English (EN) (255.77 KB - PDF)

Opublikowane po raz pierwszy: Ostatnia aktualizacja:
Zobacz

Share this page